| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
| Ausblick | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 98.93 |
| The Vanguard Group, Inc. | 11.06 |
| Vanguard Group, Inc. (Subfiler) | 10.84 |
| Capital Research & Management Co. (World Investors) | 9.39 |
| Capital Research & Management Co. (World Investors) | 9.16 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 6.87 |
| Wellington Management Co. LLP | 5.82 |
| Wellington Management Co. LLP | 5.09 |
| State Street Corp. | 4.20 |
| Capital Research & Management Co. (Global Investors) | 3.96 |
| American Funds Small Cap World Fund | 3.70 |
| T. Rowe Price Investment Management, Inc. | 3.67 |
| BlackRock Fund Advisors | 3.51 |
| Fidelity Management & Research Co. LLC | 3.45 |
| American Funds Fundamental Investors | 3.30 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 11'000 | 10'000 | 10'500 | 14'000 | 15'000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1.72 | 1.68 | 1.84 | 1.98 | 2.13 |
Bilanz (in Mio. EUR) - Aktiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 6'462 | 5'967 | 7'876 | 10'064 | 10'084 |
| Summe Anlagevermögen | 3'105 | 3'446 | 4'448 | 5'156 | 5'473 |
| Summe Aktiva | 7'160 | 6'796 | 9'561 | 12'223 | 12'329 |
Bilanz (in Mio. EUR) - Passiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 1'458 | 1'486 | 2'352 | 2'526 | 2'509 |
| Summe Fremdkapital | 5'513 | 4'836 | 7'465 | 9'593 | 9'365 |
| Summe Eigenkapital | 1'647 | 1'960 | 2'096 | 2'630 | 2'964 |
| Summe Passiva | 7'160 | 6'796 | 9'561 | 12'223 | 12'329 |
Adresse
| 200 Oceangate, 90802 Long Beach | |
| Telefon | +1 (562) 435-3666 |
| URL | http://www.molinahealthcare.com |
Management
|
Amir Desai
Chief Information Officer |
|
Barbara L. Brasier
Independent Director |
|
Carolyn Ingram
Chief Marketing Officer |
|
Dale B. Wolf
Non-Executive Chairman |
|
Daniel Cooperman
Independent Director |
|
James E. Woys
Chief Operating Officer |
|
Jason Dees
Chief Medical Officer |
|
Jeff D. Barlow
Secretary & Chief Legal Officer |
|
Joseph Krocheski
Senior Vice President-Investor Relations |
|
Joseph M. Zubretsky
President, Chief Executive Officer & Director |
|
Lawrence D. Anderson
Chief Human Resources Officer |
|
Marc S. Russo
Executive Vice President-Medicaid Health Plan |
|
Mark L. Keim
Chief Financial Officer |
|
Maurice S. Hebert
Chief Accounting Officer |
|
Richard C. Zoretic
Independent Director |
|
Richard M. Schapiro
Independent Director |
|
Ronald M. Kurtz
Chief of Staff |
|
Ronna E. Romney
Vice Chairman |
|
Stephen H. Lockhart
Independent Director |
|
Steve O'Dell
Senior VP-Growth & Corporate Development |
|
Steven J. Orlando
Independent Director |